tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Avidity Biosciences Reports Increased Revenue Amid Losses
PremiumCompany AnnouncementsAvidity Biosciences Reports Increased Revenue Amid Losses
2M ago
Avidity Biosciences reports Q3 EPS ($1.27), consensus ($1.10)
Premium
The Fly
Avidity Biosciences reports Q3 EPS ($1.27), consensus ($1.10)
2M ago
RNA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
RNA Earnings this Week: How Will it Perform?
2M ago
Avidity Biosciences downgraded to Neutral from Buy at Chardan
PremiumThe FlyAvidity Biosciences downgraded to Neutral from Buy at Chardan
2M ago
Avidity Biosciences downgraded to Sector Perform from Outperform at RBC Capital
Premium
The Fly
Avidity Biosciences downgraded to Sector Perform from Outperform at RBC Capital
2M ago
Midday Fly By: Novartis to buy Avidity, Keurig Dr Pepper beats expectations
Premium
The Fly
Midday Fly By: Novartis to buy Avidity, Keurig Dr Pepper beats expectations
2M ago
Morning Movers: Keurig Dr Pepper jumps after third quarter results
PremiumThe FlyMorning Movers: Keurig Dr Pepper jumps after third quarter results
2M ago
Avidity acquisition has positive read for Dyne Therapeutics, says Morgan Stanley
Premium
The Fly
Avidity acquisition has positive read for Dyne Therapeutics, says Morgan Stanley
2M ago
Avidity Biosciences moved to No Rating at BofA
Premium
The Fly
Avidity Biosciences moved to No Rating at BofA
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100